Reverse transcriptase-associated ribonuclease H activity as a target for antiviral chemotherapy

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 3, 1997, Pages 173-185

  Rausch, J W ^a   Le Grice, S F J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

inhibitors and inhibition; mechanisms of hydrolysis; Retroviruses; ribonuclease H; specialized activities

Indexed keywords

CEPHALOSPORIN DERIVATIVE; DNA; ENZYME INHIBITOR; GLYCOPROTEIN GP 120; HP 035; ILLIMAQUINONE; NOVEMAMINE DERIVATIVE; NUCLEOTIDE DERIVATIVE; POLYANION; RIBONUCLEASE H; RNA; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; ZIDOVUDINE; ZIDOVUDINE 5' TRIPHOSPHATE;

ANTIVIRAL ACTIVITY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

EID: 0030943865     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800301     Document Type: Review

References (84)

1. Allen SJW, Krawczyk SH, McGee LR, Bischofberger N, Mulato AS & Cherrington JM (1996) Inhibition of HIV-1 RNase H activity by nucleotide dimers and monomers. Antiviral Chemistry and Chemotherapy 7: 37-45.
2. Althaus IW, Franks KM, Langley KB, Kezdy FJ, Peterson T, Buxser SE, Decker DE, Dolak LA, Ulrich RG & Reusser F (1996) The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H. Experientia 52: 329-335.
3. Arts EJ, Ghosh M, Ehresmann B & Le Grice SFJ (1996) Restoration of tRNA-primed (-) strand DNA synthesis to a reverse transcriptase mutant with tRNA/DNA chimeras: tRNA-viral RNA duplexes and initiation of HIV replication. Journal of Biological Chemistry 271: 9054-9061.
4. Barat C, Lullien V, Schatz O, Kieth G, Nugeyre MT, Gruninger-Leitch F, Barre-Sinoussi F, Le Grice SFJ & Darlix J-L (1989) HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer. EMBO Journal 8: 3279-3285.
5. Lys,3 with reverse transcriptase and nucleocapsid protein. Journal of Molecular Biology 231: 185-190.
6. Becerra SP, Clore GM, Gronenborn AM, Kasrlstrom AR, Stahl SJ, Wilson SH & PT Wingfield (1990) Purification and characterisation of the RNaseH domain of HIV-1 reverse transcriptase expressed in recombinant Escherichia coli. FEBS Letters 270: 76-80.
7. Ben-Artzi H, Zeelon E, Gorecki M & Panet A (1992a) Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase. Proceedings of the National Academy of Sciences, USA 89: 927-931.
8. Ben-Artzi H, Zeelon E, Le Grice SFJ, Gorecki M & Panet A (1992b) Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptase. Nucleic Acids Research 20: 5115-5118.
9. Ben-Artzi H, Shemesh J, Zeelon E, Amit B, Kleiman L, Gorecki M & Panet A (1996) Molecular analysis of the second template switch during reverse transcription of the HIV RNA template. Biochemistry 35: 10549-10557.
10. Beese LS & Steitz TA (1991) Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO Journal 10: 25-33.
11. Blain SW & Goff SP (1993) Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities. Journal of Biological Chemistry 268: 23585-23592.
12. Bowman EH, Pathak VK & Hu WS (1996) Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNAs. Journal of Virology 70: 1687-1694.
13. Broder S (1990) Pharmacodynamics of 2′,3′-dideoxycytidine: an inhibitor of human immunodeficiency virus. American Journal of Medicine. 88: Supplementum, 2-7.
14. Cameron CE, Ghosh M, Le Grice SFJ & Benkovic SJ (1997) Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein. Proceedings of the National Academy of Sciences, USA 94: (in press).
15. Champoux JJ, Gilboa E & Baltimore D (1984) Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase. Journal of Virology 49: 686-691.
16. Charneau P & Clavel F (1991) A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. Journal of Virology 65: 2415-2421.
17. Charneau P, Alizon M & Clavel F (1992) A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. Journal of Virology 66: 2814-2820.
18. Charneau P, Mirambeau G, Roux P, Paulous S, Bue H & Clavel F (1994) HIV-1 reverse transcription. A termination step at the center of the genome. Journal of Molecular Biology 241: 651-662.
19. Cirino NM, Kalayjian RC, Jentoft JE & Le Grice SFJ (1993) Fluorimetric analysis of recombinant p15 HIV-1 RNaseH. Journal of Biological Chemistry 268: 14743-14749.
20. Cirino NM, Cameron CE, Smith JS, Rausch JW, Roth MJ, Benkovic SJ & Le Grice SFJ (1995) Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. Biochemistry 34: 9936-9943.
21. Coates JA, Cammack N, Jenkinson HJ, Jowett AJ, Jowett MI, Pearson BA, Penn CR, Rouse PL, Viner KC & Cameron JM (1992) (-)-2′-Deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro. Antimicrobial Agents and Chemotherapy 36: 733-739.
22. Davies JF, Hostomska Z, Hostomsky Z, Jordan SR & Matthews DA (1991) Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 252: 88-95.
23. DeStefano JJ (1995) The orientation of binding of human immunodeficiency virus reverse transcriptase on nucleic acid hybrids. Nucleic Acids Research 23: 3901-3908.
24. DeStefano JJ, Mallaber LM, Fay PJ & Bambara RA (1994) Quantitative analysis of RNA cleavage during RNA-directed DNA synthesis by human immunodeficiency and avian myeloblastosis virus reverse transcriptases. Nucleic Acids Research 22: 3793-3800.
25. Deutscher MP (1993) Ribonuclease multiplicity, diversity and complexity. Journal of Biological Chemistry 268: 13011-13014.
26. Devineni D & Gallo JM (1995) Zalcitabine. Clinical pharmacokinetics and efficacy. Clinical Pharmacokinetics 28: 351-360.
27. Erickson JW & Burt SK (1996) Structural mechanisms of HIV drug resistance. Annual Reviews of Pharmacology and Toxicology 36: 545-571.
28. Lys,3 primer excision. Biochemistry 30: 7041-7046.
29. Furfine ES & Reardon JE (1991b) Reverse transcriptase RNase H from the human immunodeficiency virus. Journal of Biological Chemistry 266: 406-412.
30. Ghosh M, Howard KJ, Cameron CE, Benkovic SJ, Hughes SH & Le Grice SFJ (1995) Truncating α-helix E′ of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer. Journal of Biological Chemistry 271: 7068-7076.
31. Götte M, Fackler S, Hermann T, Perola E, Cellai L, Gross HJ, Le Grice SFJ & Heumann H (1995) HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA. EMBO Journal 14: 833-841.
32. Grob PM, Wu JC, Cohen KA, Ingraham RH, Shih CK, Hargrave KD, McTague S & Merluzzi VJ (1992) Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug. AIDS Research and Human Retroviruses 8: 145-152.
33. Hafkemeyer P, Neftel K, Hobi R, Pfaltz A, Lutz H, Luthi K, Focher F, Spadari S & Hubscher U (1991) HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H. Nucleic Acids Research 19: 4059-4065.
34. Hostomsky Z, Hughes SH, Goff SP & Le Grice SFJ (1994) Redesignation of the ribonuclease D activity of retroviral reverse transcriptase as RNaseH*. Journal of Virology 68: 1970-1971.
35. Huber HE & Richardson CC (1990) Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase. Journal of Biological Chemistry 265: 10565-10573.
36. Hungnes O, Tjotta E & Grinde B (1991) The plus strand is discontinuous in a subpopulation of unintegrated HIV-1 DNA. Archives of Virology 116: 133-141.
37. Hungnes O, Tjotta E & Grinde B (1992) Mutations in the central polypurine tract of HIV-1 result in delayed replication. Virology 190: 440-442.
38. Jacobo-Molina A, Ding J, Nanni RG, Clark AD, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, Hizi A, Hughes SH & Arnold EA (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proceedings of the National Academy of Sciences, USA 90: 6320-6324.
39. Jacques PS, Wöhrl BM, Howard KJ & Le Grice SFJ (1994) Modulation of HIV-1 reverse transcriptase function in 'selectively deleted' p66/p51 heterodimers. Journal of Biological Chemistry 269: 1388-1393.
40. Kashiwagi T, Jeanteur D, Haruki M, Katayanagi K, Kanaya S & Morikawa K (1996) Proposal for new catalytic roles for two invariant residues in Escherichia coli ribonclease H. Protein Engineering 9: (in press).
41. Katayanagi K, Mivagawa M, Matsushima M, Ishikawa M, Kanaya S, Nakamura H, Ikehara M, Matsuzaki T & Morikawa K (1992) Structural details of ribonuclease H from Escherichia coli refined to an atomic resolution. Journal of Molecular Biology 223: 1029-1052.
42. 2+ at 2.8 Å resolution: proof for a single Mg(2+)-binding site. Proteins 17: 337-346.
43. Kohlstaedt LA, Wang J, Friedman M, Rice PA & Steitz TA (1992) Crystal structure at 3.5Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 1783-1790.
44. Koo H-S, Wu H-M & Crothers DM (1986) DNA bending at adenine:thymine tracts. Nature 320: 501-506.
45. Lapadat-Tapolsky M, Pernelle C, Borie C & Darlix J-L (1995) Analysis of nucleic acid annealing activities of nucleocapsid protein from HIV-1. Nucleic Acids Research 23: 2434-2441.
46. Le Grice SFJ (1995) Qualitative assessment of HIV-1 reverse transcriptase activities: a need for improved drug screening methods. Protein and Peptide Letters 2: 381-390.
47. Le Grice SFJ, Cameron CE & Benkovic SJ (1995) Purification of retroviral reverse transcriptase. Methods in Enzymology 262: 130-147.
48. Lys,3 in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. Journal of Virology 70: 4996-5004.
49. Loya S & Hizi A (1993) The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia viruses. Journal of Biological Chemistry 268: 9323-9328.
50. Loya S, Tal R, Kashman Y & Hizi A (1990) Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. Antimicrobial Agents and Chemotherapy 34: 2009-2012.
51. Metzger W, Hermann T, Schatz O, Le Grice SFJ & Heumann H (1993) Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template/primer complexes. Proceedings of the National Academy of Sciences, USA 90: 5909-5913.
52. Mizrahi V, Usdin MT, Harington A & Dudding LR (1990) Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase. Nucleic Acids Research 18: 5359-5363.
53. Moelling K, Schulze T & Diringer H (1989) Inhibition of human immunodeficiency virus by sulfated polyanions. Journal of Virology 63: 5489-5491.
54. Nelson HCM, Finch JT, Luisi BF & Klug A (1987) The structure of an oligo(dA):oligo(dT) tract and its biological implications. Nature 330: 221-226.
55. Trp primer molecule from viral DNA by ribonuclease H during reverse transcription. Cell 30: 797-805.
56. Palaniappan C, Fuentes GM, Rodriguez-Rodriguez L, Fay PJ & Bambara RA (1996) Helix structure and ends of RNA/DNA hybrids direct the cleavage specificity of HIV-1 reverse transcriptase RNase H. Journal of Biological Chemistry 271: 2063-2070.
57. Panganiban AT & Temin HM (1983) The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature 306: 155-160.
58. Peliska JA & Benkovic SJ (1992) Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258: 1112-1118.
59. Peliska JA, Balasubramanian S, Giedroc DP & Benkovic SJ (1994) Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33: 13817-13823.
60. Powell MD & Levin JG (1996) Sequence and structural determinants required for plus-strand DNA synthesis by the HIV-1 polypurine via. Journal of Virology 70: 5288-5296.
61. Pullen KA & Champoux JJ (1990) Plus-strand origin for human immunodeficiency virus type 1: implications for integration. Journal of Virology 64: 6274-6277.
62. Pullen KA & Champoux JJ (1992) Incomplete removal of the RNA primer for minus strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Journal of Virology 66: 367-373.
63. Pullen KA, Rattray A & Champoux JJ (1993) The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. Journal of Biological Chemistry 266: 6221-6227.
64. Rattray AJ & Champoux JJ (1989) Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H. Journal of Molecular Biology 208: 445-456.
65. Rausch JW & Le Grice SFJ (1997) Substituting a conserved residue of the RNase H domain alters substrate recognition by retroviral reverse transcriptase. Journal of Biological Chemistry 272: (in press).
66. Rodgers DW, Gamblin SJ, Harris BA, Ray S, Culp JS, Hellmig B, Woolf DJ, Debouck C & Harrison SC (1995) The structure of unliganded reverse transcriptase from HIV-1. Proceedings of the National Academy of Sciences, USA 92: 1222-1226.
67. Rodriguez-Rodriguez L, Tsuchihashi Z, Fuentes GM, Bambara RA & Fay PJ (1995) Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. Journal of Biological Chemistry 270: 15005-15011.
68. Schatz O, Cromme F, Grüninger-Leitch F & Le Grice SFL (1989) Point mutations within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function. FEBS Letters 257: 311-314.
69. Schatz O, Cromme F, Naas T, Lindemann D, Gruninger-Leitch F, Mous J & Le Grice SFJ (1990a) Inactivation of the RNaseH domain of HIV-1 reverse transcriptase blocks viral infectivity. In Oncogenesis and AIDS. Edited by TS Papas. Houston: Portfolio Publishing Company, pp. 293-303.
70. Schatz O, Mous J & Le Grice SFJ (1990b) HIV-1 RT-associated ribonuclease H displays both endonuclease and 3′→5′ exonuclease activity. EMBO Journal 9: 1171-1176.
71. Skalka AM & Goff SP (editors) (1993) Reverse Transcriptase. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
72. Smith JK, Cywinski A & Taylor JM (1984) Specificity of initiation of plus-strand DNA by Rous sarcoma virus. Journal of Virology 52: 314-319.
73. Smith JS & Roth MJ (1992) Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3). Journal of Biological Chemistry 267: 15071-15079.
74. Sorge J & Hughes SH (1982) Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function. Journal of Virology 43: 482-488.
75. Stammers DK, Tisdale M, Court S, Parmar V, Bradley C & Ross CK (1991) Rapid purification and characterisation of HIV-1 reverse transcriptase and RNaseH engineered to incorporate a C-terminal tripeptide α-tubulin epitope. FEBS Letters 283: 298-302.
76. Tan C-K, Civil R, Mian AM, So AG & Downey KM (1991) Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidine. Biochemistry 30: 4831-4834.
77. Telesnitsky A, Blain SW & Goff SP (1992) Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli ribonuclease H. Journal of Virology 66: 615-622.
78. Tisdale M, Schulze T, Larder BA & Moelling K (1991) Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish viral infectivity. Journal of General Virology 72: 59-66.
79. Tsuchihashi Z & Brown PO (1994) DNA strand exchange and DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. Journal of Virology 68: 5863-5870.
80. Wang J, Smerdon SJ, Jäger J, Kohlstaedt LA, Rice PA, Friedman JM & Steitz TA (1994) Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proceedings of the National Academy of Sciences, USA 91: 7242-7246.
81. Weiss R, Teich N, Varmus HE & Coffin J (editors) (1985) RNA Tumor Viruses. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
82. Williams KJ, Loeb LA & Fry M (1990). Synthesis of DNA by human immunodeficiency virus reverse transcriptase is preferentially blocked at template oligo(deoxyadenosine) tracts. Journal of Biological Chemistry 265: 18682-18689.
83. Wu W, Henderson LE, Copeland TD, Golelick RJ, Bosche WJ, Rein A & Levin JG (1996) Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. Journal of Virology 70: 7132-7142.
84. Yang W, Hendrickson WA, Crouch RJ & Satow Y (1990) Structure of ribonuclease H phased at 2Å resolution by MAD analysis of the selenomethionyl protein. Science 249: 1398-1405.